About Manhattan Pharmaceuticals
Manhattan Pharmaceuticals is a Healthcare company based in New York (United States) founded in 2003, and was acquired by TG Therapeutics in April 2012. RD company focused on manufacturing drugs for multiple therapeutic areas. Manhattan Pharmaceuticals has raised $38.64 million across 3 funding rounds from investors including TG Therapeutics. Its focus areas include Diversified Pharmaceuticals.
Company details
Manhattan Pharmaceuticals was established in 2003 in New York, United States. Focus is placed on research and development within the pharmaceutical industry. Manufacturing processes are applied to produce drugs targeting various therapeutic areas. Operations are conducted from the companys base in the United States, with emphasis on innovation in drug formulation and production for diverse medical needs.
- Headquarters New York, United States
- Stage Acquired
- SectorsHealthcare
- Website manhattanpharma.com
- Social LinkedIn
- Acquired by TG Therapeutics (Apr 2012)
- Total Equity Funding$38.64M (USD)
in 3 rounds
- Latest Funding Round$11.09M (USD), Series A
Mar 2012
- Investors
- Acquired byTG Therapeutics
(Apr 2012)
Funding Insights of Manhattan Pharmaceuticals
Manhattan Pharmaceuticals has successfully raised a total of $38.64M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $11.09 million completed in March 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $38.64M
- Total Rounds 3
- Last Round Series A — $11.09M
- First Round $2.55M
(Mar 2010)
All 3 funding rounds of Manhattan Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2012 | $11.09M | Series A | – | – | – |
| Feb 2012 | $25M | Series A | – | – | – |
| Mar 2010 | $2.55M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Manhattan Pharmaceuticals
Manhattan Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include TG Therapeutics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Treatments for B-cell malignancies and autoimmune diseases are developed. | 1993 | tgtherapeutics.com | New York, United States |
Investor details for Manhattan Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Manhattan Pharmaceuticals
4 dated milestones of Manhattan Pharmaceuticals across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Manhattan Pharmaceuticals is founded.
- Funding First funding round of $2.5M.
- Funding Latest funding round, Series A, of $11.1M.
- Exit Acquired by TG Therapeutics.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Manhattan Pharmaceuticals (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Manhattan Pharmaceuticals
Manhattan Pharmaceuticals was founded in 2003 and raised its 1st funding round 7 years after it was founded.
Manhattan Pharmaceuticals is headquartered in New York, United States. It is registered at New York, New York, United States.
Manhattan Pharmaceuticals is a funded company, having raised a total of $38.64M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.55M, raised on Mar 2010.
Manhattan Pharmaceuticals was established in 2003 in New York, United States. Focus is placed on research and development within the pharmaceutical industry. Manufacturing processes are applied to produce drugs targeting various therapeutic areas. Operations are conducted from the companys base in the United States, with emphasis on innovation in drug formulation and production for diverse medical needs.
Manhattan Pharmaceuticals has 1 investor. Key investors include TG Therapeutics.
Yes. Manhattan Pharmaceuticals was acquired by TG Therapeutics in April 2012.